ZNF791 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.89380000001649E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.382170E-02 |
Normal-vs-Stage2 |
3.991500E-02 |
Normal-vs-Stage3 |
1.81430000023575E-07 |
Normal-vs-Stage4 |
1.8461999706787E-09 |
Stage1-vs-Stage2 |
5.056600E-01 |
Stage1-vs-Stage3 |
1.638520E-04 |
Stage1-vs-Stage4 |
1.38999999999001E-06 |
Stage2-vs-Stage3 |
1.154750E-01 |
Stage2-vs-Stage4 |
2.824400E-02 |
Stage3-vs-Stage4 |
3.200800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.61860000000136E-05 |
Normal-vs-AfricanAmerican |
1.04599999994903E-06 |
Normal-vs-Asian |
2.381600E-01 |
Caucasian-vs-AfricanAmerican |
6.724900E-03 |
Caucasian-vs-Asian |
8.343600E-01 |
AfricanAmerican-vs-Asian |
2.306200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.05560000005245E-06 |
Normal-vs-Female |
3.770400E-04 |
Male-vs-Female |
3.831000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.794800E-04 |
Normal-vs-Age(41-60Yrs) |
1.344680E-03 |
Normal-vs-Age(61-80Yrs) |
2.59120000001278E-06 |
Normal-vs-Age(81-100Yrs) |
9.166100E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.972030E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.892000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.406600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.176030E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.942600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.560000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.867400E-01 |
Normal-vs-Grade 2 |
4.574400E-02 |
Normal-vs-Grade 3 |
9.96599999969483E-07 |
Normal-vs-Grade 4 |
1.36639588532717E-11 |
Grade 1-vs-Grade 2 |
1.935760E-01 |
Grade 1-vs-Grade 3 |
3.343100E-03 |
Grade 1-vs-Grade 4 |
1.66553999999541E-05 |
Grade 2-vs-Grade 3 |
2.630800E-04 |
Grade 2-vs-Grade 4 |
5.0474000534706E-09 |
Grade 3-vs-Grade 4 |
1.703350E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.521000E-01 |
Normal-vs-ccB subtype |
2.83710000048565E-07 |
ccA subtype-vs-ccB subtype |
1.48190000048842E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.181310E-04 |
Normal-vs-N1 |
4.368700E-04 |
N0-vs-N1 |
1.997640E-01 |
|
|